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Background: Current medical practice urges individual health care facilities and medical professionals to obtain and
provide detailed insight in quality of care with the possibility of comparing data between institutions. Adverse event (AE)
analysis serves as a mainstay in quality assessment in vascular surgery, but the comparison of AE data between facilities
can be complex. The aim of the present study was to assess independent risk factors for AE occurrence: patient, disease and
operation characteristics besides general differences between health care facilities.
Methods: All AEs after infrainguinal bypass graft procedures (BGPs) in three health care facilities in the Netherlands were
evaluated. AEs were defined identically in the facilities.
Results:Of 601 BGPs performed, 662 AEs were registered. Independent predictors of AEs were female gender (odds ratio
[OR], 2.13; 95% confidence interval [CI], 1.39-3.26; P < .01), age >60 years (OR, 0.57; 95% CI, 0.34-0.95; P  .03),
American Society of Anesthesiologists classification 3-4 (OR, 1.79; 95% CI, 1.01-3.17; P  .05), comorbidities of
pulmonary disease (OR, 2.99; 95%CI, 1.67-5.34; P< .01) and diabetes mellitus (OR, 2.49; 95%CI, 1.58-3.94; P< .01),
distal anastomosis level at below knee femoropopliteal BGP (OR, 2.01; 95% CI, 1.26-3.22; P < .01), femorotibial BGP
(OR, 2.40; 95% CI, 1.37-4.19; P < .01), and popliteopedal BGP (OR, 92.39; 95% CI, 11.13-766.98; P < .01). One
health care facility had significantly fewer AEs than the other two (OR, 0.21; 95% CI, 0.13-0.35; P < .01).
Conclusion: Age, gender, comorbidity, and type of surgery are all independent predictors of AE occurrence in vascular
surgery. After adjustment for differences in these factors, one health care facility still had lower AE occurrence, which
needs to be examined further. ( J Vasc Surg 2010;51:622-7.)The currentmedical climate, characterized by increased
cost, individual patient awareness, and medicolegal con-
cerns, urges individual health care facilities and medical
professionals to obtain and provide detailed insight in the
quality of provided care. To evaluate provided care, analy-
ses of process, structure, and outcome indicators are fre-
quently reported.1,2 One of the most studied outcome
indicators is the assessment of incidences of adverse events
(AEs).
Evaluating AEs can raise the awareness of shortcomings
in surgical practice and increase transparency in provided
care. Through analysis of AEs, one can learn from them,
and through study of the cause of the occurrence of the
AEs, one can try to decrease the number and severity of AEs
in the future.3-5 Therefore, AEs can be used as outcome
measures to assess the quality of surgical care.6-8
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622Owing to extensive comorbid conditions and techni-
cally challenging surgical revascularization procedures, pa-
tients treated for peripheral arterial occlusive disease (PAOD)
are at high risk for developing AEs. Rutherford et al9,10
proposed an AE registration classification. However, the liter-
ature shows inconsistency in defining, documenting, and clas-
sifying AEs, resulting in diverse interpretations of AE anal-
ysis.8,11,12
The Association of Surgeons of the Netherlands
(ASN)13 developed a uniform definition of an AE. Three
teaching hospitals in the Netherlands—the Department of
Vascular Surgery of the St. Elisabeth Hospital in Tilburg
(EH),3,8,14 the Red Cross (RCH) and the Leyweg loca-
tions in The Hague of the Haga Hospital,4-6,15-24 and the
Leiden University Medical Centre (LUMC)13,25-27—used
this definition and have been documenting AEs prospec-
tively according to this definition for 15 years.
The aim of the present study was to assess the indepen-
dent risk factors for AE occurrence after peripheral arterial
bypass graft procedures (BGP) of patient, disease, and
operation characteristics besides general differences be-
tween health care facilities.
METHODS
Patients. Between January 2000 and January 2005,
601 consecutive patients were treated with a BGP for
PAOD at the surgical departments of the EH, the RCH,
and in the LUMC in the Netherlands. These three health
care facilities are teaching hospitals. Criteria for treatment
were intermittent claudication (IC) or critical lower limb
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fort, or weakness that is consistently produced by the same
amount of walking or equivalent muscular activity in a
given patient and that is promptly relieved by cessation of
that activity with a pain-free walking distance (PFWD)
100 m and an ankle pressure after exercise 50 mm HG
(Fontaine stage IIb). This corresponds with category 3 of
the Society for Vascular Surgery/North American Chapter
of the International Society for Cardiovascular Surgery
(SVS/ISCVS) standards.9,10 CLI was defined as ischemic
rest pain (Fontaine classification 3) with a resting ankle
pressure 40 mm Hg and gangrene or nonhealing isch-
emic ulceration (Fontaine classification 4) with a resting
ankle pressure 60 mm Hg. This corresponds with cate-
gories 4, 5, and 6 of the SVS/ISCVS standards.
Risk factors and comorbidities. Risk factors and co-
morbidities were registered prospectively of all patients
during their admission intake. Smoking, hypertension, car-
diac disease, hyperlipidemia, diabetes mellitus, renal dis-
ease, pulmonary disease, carotid disease, and age were
classified according to the SVS/ISCVS standards and ac-
cording to the Trans-Atlantic InterSociety Consensus Doc-
ument on Management of Peripheral Arterial Disease
(TASC).28 Risk factor and comorbidity management, ac-
cording to TASC and the American Heart Association/
American College of Cardiology (AHA/ACC),29 were
conducted by a vascular specialist or cardiologist preoper-
atively in the out-patient clinic or during admission before
operation when an urgent intervention was indicated. The
American Society of Anesthesiologists (ASA) classifica-
tion30 of patients was determined according to their gen-
eral preoperative condition prospectively.
Revascularization. Vascular treatment by infraingui-
nal BGPs was performed according to standard vascular
techniques, using preferably reversed vein for infrainguinal
femoropopliteal, crural, or pedal BGPs. All vascular opera-
tions were performed by or under the supervision of a
vascular surgeon. The decision to intervene and the type of
intervention were driven by the SVS/ISCVS and TASC
reporting standards.
Adverse events. The Association of Surgeons of the
Netherlands (ASN) has agreed on a common definition of
AEs.13,26,31 This definition differs from that used in other
studies because it was chosen with the explicit aim of
excluding subjective judgment on cause and effect, and
right and wrong. The definition of an AE is:
An unintended and unwanted event or state occurring
during or following medical care, that is so harmful to a
patient’s health that (adjustment of) treatment is required
or that permanent damage results. The AE may be noted
during hospitalization, until 30 days after discharge or
transfer to another department. The intended result of
treatment, the likelihood of the adverse outcome occurring,
and the presence or absence of a medical error causing it, is
irrelevant in identifying an adverse outcome.
All three health care facilities registered AEs according to
this definition.Statistical analysis. Patients with and without AE
were compared on several characteristics using 2 tests. If
the expected count of a variable was less than five, the
Fisher-exact test was used. This was done both for patient
characteristics (age, gender), disease/health status of the
patient (ASA, PAOD), comorbidity (cardiac, pulmonary,
renal, carotid disease, diabetes mellitus), tobacco use, and
type of bypass procedure. We also included a variable of the
hospital where patients were treated to take into account
any remaining variation.
The variables showing significant differences between
patients with and without AEs were included in the multi-
variable logistic regression analysis with AE occurrence as
the dependent variable. The same analysis was done with
specific types of AEs as the dependent variable to assess
whether these were risk factors for specific types of AEs or
for AEs in general. In addition to this full model including
all variables, we also assessed whether a limited model
would fit the data just as well, including only those variables
readily available in most registries. This will give some
estimate about whether the additional effort of collecting
extra information, as done in the present study, is worth-
while. The Nagelkerke R2 was used as a measure of the
goodness-of-fit, indicating the percentage of the variance in
AE occurrence that is explained by the variables included in
the model.
For all statistical analyses, a value of P  .05 was consid-
ered statistically significant. Statistical analyseswere performed
using SPSS 16.0 software (SPSS Inc, Chicago, Ill).
RESULTS
Patients and AE. During the study period, 371 men
(61.7%) and 230 women (38.3%) underwent surgical treat-
ment because of PAOD. Mean age was 72.6 years (range,
35-94 years). AEs were prospectively reported in 283 pa-
tients (47.3%) during the 30-day postoperative period,
with a total of 662 AEs (Table I). Most AEs concerned the
(sub)cutis (31.4%), vascular management (23.4%), or the
cardiac system (12.4%).
Risk factors of AEs. As summarized in Table II,
patients with AEs more often were women, 60 years of
age, at ASA 3, treated for CLI, had cardiac, pulmonary,
renal, carotid disease, or diabetes mellitus, were smokers,
and underwent a below knee BGP. Fewer patients with AEs
were treated in health care facility 2 than in the other two.
This was confirmed in multivariable analysis that showed
the independent risk factors for AE occurrence were female
gender, age 60 years, ASA 3 or 4, pulmonary disease,
diabetes mellitus, and all three below knee BGPs (Table
III). Furthermore, health care facility 2 had significantly
lower AE occurrence after adjustment for the above differ-
ences in patient, disease, and operation characteristics. This
full model, including all of these variables, fit the data rather
well, explaining 44% of the variance in AE occurrence
(Table III).
If only age, gender, ASA class, type of BGP, and
hospital were included in themultivariable analysis, because
these are readily available in most registries, similar results
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class 3 and 4 (Table IV). It is likely that part of the
comorbidity is now included in the higher ASA classes,
resulting in a higher excess risk. With such a limited model,
including only variables readily available in most registries,
still a rather good fit of the data is obtained, explaining 39%
of the variance in AE occurrence by this limited set of
variable (Table IV).
To assess whether these risk factors were found for all
Table I. Adverse events (n  662) after treatment for
peripheral arterial occlusive disease in the sample of 601
patients
Adverse events No. (%)
Cardiac 82 (12.4)
Congestive heart failure 31 (4.7)
Arrhythmia 12 (1.8)
Cardiac arrest 8 (1.2)
Myocardial infarction 26 (3.9)
Tachycardia/bradycardia 3 (0.5)
Endocarditis/pericarditis 1 (0.2)
Other 1 (0.2)
Pulmonary 27 (4.1)
Respiratory insufficiency 6 (0.9)
Aspiration/pneumonia 21 (3.2)
Neurology 20 (3.0)
Cerebrovascular accident 6 (0.9)
Neurapraxia 4 (0.6)
Other 10 (1.5)
Renal 39 (5.9)
Renal failure 9 (1.4)
Urinary tract infection 18 (2.7)
Urinary retention 12 (1.8)
(Sub)cutis 208 (31.4)
Blister or ulcer 11 (1.7)
Abscess 16 (2.4)
Seroma 7 (1.1)
Cellulites 8 (1.2)
Wound hematoma 10 (1.5)
Wound infection 98 (14.8)
Wound dehiscence 21 (3.2)
Necrosis or tissue loss 37 (5.6)
Muscles and skeleton 5 (0.8)
Compartmental syndrome 3 (0.5)
Osteomyelitis 2 (0.3)
Hematology 28 (4.2)
Thrombocytopenia 3 (0.5)
Septicemia 20 (3)
Fluid and electrolytes 5 (0.8)
Vascular management 155 (23.4)
Line infection 5 (0.8)
Deep venous thrombosis 3 (0.5)
Bypass graft procedure
Infection 6 (0.9)
Stenosis 12 (1.8)
Occlusion 81 (12.2)
Hemorrhage 48 (7.3)
General management 98 (14.8)
Error in (Appendix 3) 27 (4.1)
Delay in (Appendix 3) 48 (7.3)
Incomplete hospital record 23 (3.5)
Total adverse events 662 (100)
Patients with adverse events 283 (47.3)types of AEs or just for specific groups, the same analyseswere performed for the largest groups of AEs in Table I,
comprising cardiac, (sub)cutis, and vascular management.
Gender and ASA classification were not found as indepen-
dent risk factors for these three AE groups (data not
shown). The lower AE occurrence in patients aged 60
years was only found for vascular management AEs (odds
ratio [OR], 0.43; 95% confidence interval [CI], 0.24-
0.77). Diabetes mellitus on the other hand, consistently
increased the incidence in all three groups of AEs (cardiac:
OR, 2.37 [95% CI, 1.20-4.67]; (sub)cutis: OR, 2.44 [95%
CI, 1.58-3.77]; vascular management: OR, 2.38 [95% CI,
1.42-3.96]), as did smoking (cardiac: OR, 2.40 [95% CI,
Table II. Differences in patient, disease, and procedure
characteristics between patients with and without adverse
events
Characteristics, %
Without
AEs
(n  318)
With AEs
(n  283)
Test of
difference
2 P
Gender 6.11 .01
Male 66.4 56.5
Female 33.6 43.5
Age, % 4.17 .04
60 years 83 76.3
ASA classification 94.97 .01
1-2 69.5 29.7
3-4 30.5 70.3
PAOD, % 21.83 .01
Intermittent claudication 38.4 20.8
Critical limb ischemia 61.6 79.2
Comorbidity (SVS/ISCVS)
Cardiac disease 38.46 .01
No 63.8 38.5
Yes 36.2 61.5
Pulmonary disease 27.38 .01
No 89.6 73.1
Yes 10.4 26.9
Renal disease 6.22 .01
No 95.6 90.5
Yes 4.4 9.5
Carotid disease 8.43 .01
No 89.3 80.9
Yes 10.7 19.1
Diabetes mellitus 34.47 .01
No 77.7 55.1
Yes 22.3 44.9
Tobacco use 5.98 .01
No 48.4 38.5
Yes 51.6 61.5
Bypass graft procedure 61.56 .01
Femoropopliteal, AK 51.9 27.9
Femoropopliteal, BK 31.8 36.7
Femorotibial 16 23.3
Popliteopedal 0.3 12
Health care facility 88.76 .01
Facility 1 22.3 48.8
Facility 2 62.9 24.7
Facility 3 14.8 26.5
AE, Adverse event; AK, above knee; ASA, American Society of Anesthesi-
ologists; BK, below knee; PAOD, peripheral arterial occlusive disease;
SVS/ISCVS, Society of Vascular Surgery/North American Chapter of the
International Society for Cardiovascular Surgery.1.03-5.58]; (sub)cutis: OR, 1.69 [95% CI, 1.06-2.67];
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Pulmonary comorbidity was only found to increase the
occurrence of cardiac AEs (OR, 4.58; 95% CI, 2.21-9.51).
Table III. Determinants for adverse event occurrence:
multivariate analysis (full model)a
Characteristics OR 95% CI Pb
Gender
Female vs male 2.13 (1.39-3.26) .01
Age
Age 60 vs 60 years 0.57 (0.34-0.95) .03
ASA classification
3-4 vs 1-2 1.79 (1.01-3.17) .05
PAOD
CLI vs IC 0.68 (0.40-1.16) .16
Comorbidity (SVS/ISCVS)
Cardiac disease (yes/no) 1.62 (0.97-2.68) .06
Pulmonary disease (yes/no) 2.99 (1.67-5.34) .01
Renal disease (yes/no) 1.31 (0.55-3.12) .54
Carotid disease (yes/no) 1.67 (0.94-2.97) .08
Diabetes mellitus (yes/no) 2.49 (1.58-3.94) .01
Tobacco use (yes/no) 1.32 (0.86-2.02) .2
Bypass graft procedure
(Ref  Femoropopliteal, AK)
Femoropopliteal, BK 2.01 (1.26-3.22) .01
Femorotibial 2.4 (1.37-4.19) .01
Popliteopedal 92.39 (11.13-766.98) .01
Health care facility
(Ref  Facility 1)
Facility 2 0.21 (0.13-0.35) .01
Facility 3 1.14 (0.66-1.98) .63
AE, adverse event; AK, above knee; ASA, American Society of Anesthesiol-
ogists; BK, below knee; CI, confidence interval; CLI, critical limb ischemia;
IC, intermittent claudication; OR, odds ratio; PAOD, peripheral arterial
occlusive disease; SVS/ISCVS, Society of Vascular Surgery/North American
Chapter of the International Society for Cardiovascular Surgery.
aModel fit: Nagelkerke R2  0.44.
bValues of P  .05 are significant.
Table IV. Determinants for adverse event occurrence:
multivariate analysis (limited model)a
Characteristics OR 95% CI Pb
Gender
Female vs male 2 (1.33-3.01) .01
Age
Age 60 vs 60 years 0.47 (0.29-0.76) .01
ASA classification
3-4 vs 1-2 3.38 (2.26-5.07) .01
Bypass graft procedure
(Ref  Femoropopliteal, AK)
Femoropopliteal, BK 1.82 (1.17-2.84) .01
Femorotibial 2.52 (1.50-4.22) .01
Popliteopedal 78.06 (9.89-616.16) 0.01
Health care facility
(Ref  Facility 1)
Facility 2 0.27 (0.17-0.44) .01
Facility 3 1.2 (0.72-1.99) .48
AK, above knee; ASA, American Society of Anesthesiologists; BK, below
knee; CI, confidence interval; OR, odds ratio.
aModel fit: Nagelkerke R2  0.39.
bValues of P  .05 are significant.The incidence of vascular management AEs was increasedin all three below knee BGPs compared with above knee
BGP (femoropopliteal BGP: OR, 2.06 [95% CI, 1.11-
3.83]; femorotibial BGP: OR, 3.23 [95% CI, 1.64-6.38];
popliteopedal BGP: OR, 16.74 [95% CI, 6.43-43.60])
.The incidence of (sub)cutis AEs was only increased for
popliteopedal BGP (OR, 3.02 [95% CI, 1.29-7.05]).
Health care facility 2 had consistently lower occurrences in
all three AE groups (cardiac: OR, 0.20 [95% CI, 0.08-
0.51]; (sub)cutis: OR 0.40 [0.24-0.69]; vascular manage-
ment: OR, 0.33 [0.18-0.62]).
DISCUSSION
The primary goal of this study was to assess indepen-
dent risk factors for AE occurrence after peripheral arterial
BGP: patient, disease, and operation characteristics besides
general differences between health care facilities.
In this study, 661 AEs were registered in 601 patients,
and one or more AEs were documented in 47% of all
patients undergoing BGP. As expected, patients undergo-
ing peripheral arterial BGP frequently have extensive co-
morbid conditions resulting in a relatively high likelihood
to experience AEs. In accordance with previous reports, the
specific patient population in our study frequently experi-
enced wound, graft, and cardiac AEs.4,18,32
Specific detailed analysis of variables related to the
occurrence of AEs was conducted. Especially, differences in
patient, disease, and procedural characteristics, as well as
differences between health care facilities, were assessed in
terms of likelihood of AEs.When patients with and without
AEs were compared by univariate analysis, female gender,
age 60 years, indication of operation (CLI vs IC) and
comorbid conditions were related to AE occurrence. The
type of operation performed was also strongly related with
the incidence of AEs. Patients undergoing distal BGP were
highly susceptible to AEs, with almost no patients without
AEs during admission.
In multivariate analysis, female gender, age, pulmonary
disease, and diabetes mellitus were independent predictive
risk factors for the occurrence of AEs. The type of operation
performedwas also strongly related to the incidence of AEs;
this result is in concordance with the literature especially in
patients undergoing distal bypasses.33
After adjustment for differences in these characteristics,
patients treated in health care facility 2 had a lower AE
occurrence than patients from the other hospitals. Similar
results occurred when only limited information readily
available in most registries was included and also fitted the
data rather well, explaining 39% instead of 44% of the
variance. The lower AE occurrence in health care facility 2
was found for cardiac, (sub)cutis, and vascular management
AEs. Diabetes mellitus,34-38 smoking,37-40 and popliteope-
dal34,35,37,38 BGP also increased the occurrence for all
three types of AE, as is well known from the literature.
The results may partially be explained by factors not
taken into account in this study. Not only are preoperative
comorbid conditions strongly associated with AEs but also
operations in patients undergoing previous vascular proce-
dures in the unilateral limb.34,41 Therefore, detailed regis-
JOURNAL OF VASCULAR SURGERY
March 2010626 Flu et altration of previous vascular interventions in the affected
limb should be documented. Furthermore, emergency op-
erations are associated with more AEs compared with elec-
tive cases,6,21,42,43 as well as a possible difference in AE
occurrence between open and endovascular procedures as a
the primary choice of treatment. These factors, which were
not measured in this study, might explain part of the lower
AE occurrence in health care facility 2, if this facility were,
for instance, to treat more patients undergoing primary
revascularization instead of redo procedures or were to
have a different mix in open and endovascular procedures.
Our results show that one health care facility had a
lower AE occurrence after adjustment for several patient,
disease, comorbidity, and operation characteristics. The
question is whether the occurrence of AEs is actually lower
or was caused by higher under-reporting or a different
interpretation of the AE definition in this facility. For
instance, a difference in reported wound infections (as one
of the possible AEs) could be caused by interobserver
variability among different physicians in different facilities
(local skin redness observed depends on day to day wound
inspection) and variability of interhealth care facility thera-
peutically prophylactic strategies (local skin redness post-
operatively treated with prophylactic antibiotics more
readily in one facility compared with another facility).
These factors are not easily measured by objective variables
but may explain a significant part of the observed difference
between health care facilities.
These results can be used in clinical practice. The
identification of risk factors for postoperative AEs is essen-
tial to balance the potential benefits and risks of surgical
interventions in individual patients. A detailed insight in
the chances of an unfavorable outcome by assessing AE
incidences (and therefore ones’ own medical performance)
in the past is paramount to choosing the appropriate surgi-
cal strategy and to provide future patients with proper
information about the risk of postoperative AEs given the
possible risk factors that these patients may have.1
A possible implication of these findings is observed differ-
ences in AE occurrence between health care facilities may
represent true differences, may be caused by other (unmea-
sured) factors, or may be induced by subtle differences in the
interpretation of the samedefinition.One of the possibilities is
to engage a teamof independent reviewers to audit a sample of
themedical records of patients with andwithout AEs to assess
whether all health care facilities interpret the definition in
exactly the same way and have similar effectiveness in report-
ing these AEs. Only then will the study of AE differences
between facilities and other factors associated with quality of
care dowhat it was initiated for in the first place: contribute to
the improvement of quality of care.
CONCLUSION
Comparison of quality of care among different health
care facilities after arterial peripheral bypass surgery by
assessing AE incidences is complex. Patient and disease
characteristics, comorbidity, and type of surgery performed
are independent risk factors for AE occurrence. If correctedfor these variables, significant differences still exist between
different health care facilities in AE incidence.
AUTHOR CONTRIBUTIONS
Conception and design: HF, AP, PM, JH, JL
Analysis and interpretation: HF, AJ, PM, JH
Data collection: HF, AP, PM, EV, CL
Writing the article: HF, AP, PM, JH
Critical revision of the article: HF, AP, PM, PB, JR, JH, JL
Final approval of the article: HF, AP, PM, PB, JR, JH, JL
Statistical analysis: HF, PM
Obtained funding: None
Overall responsibility: PB, JH, JL
REFERENCES
1. Laukontaus SJ, Aho PS, Pettila V, Alback A, Kantonen I, Railo M,
Hynninen M, Lepantalo M. Decrease of mortality of ruptured abdom-
inal aortic aneurysm after centralization and in-hospital quality improve-
ment of vascular service. Ann Vasc Surg 2007;21:580-5.
2. Rowell KS, Turrentine FE,HutterMM, Khuri SF, HendersonWG.Use
of national surgical quality improvement program data as a catalyst for
quality improvement. J Am Coll Surg 2007;204:1293-300.
3. Veen EJ, Steenbruggen J, Roukema JA. Classifying surgical complica-
tions: a critical appraisal. Arch Surg 2005;140:1078-83.
4. Schepers A, Klinkert P, Vrancken Peeters MP, Breslau PJ. Complication
registration in patients after peripheral arterial bypass surgery. Ann Vasc
Surg 2003;17:198-202.
5. Veen MR, Lardenoye JW, Kastelein GW, Breslau PJ. Recording and
classification of complications in a surgical practice. Eur J Surg 1999;
165:421-4; discussion 425.
6. KroonHM, Breslau PJ, Lardenoye JW. Can the incidence of unplanned
reoperations be used as an indicator of quality of care in surgery? Am J
Med Qual 2007;22:198-202.
7. Chassin MR. Quality of health care. Part 3: Improving the quality of
care. N Engl J Med 1996;335:1060-3.
8. Veen EJ, Janssen-Heijnen ML, Leenen LP, Roukema JA. The registra-
tion of complications in surgery: a learning curve. World J Surg 2005;
29:402-9.
9. Rutherford RB. Vascular surgery—comparing outcomes. J Vasc Surg
1996;23:5-17.
10. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et
al. Recommended standards for reports dealing with lower extremity
ischemia: Revised version. J Vasc Surg 1997;26:517-38.
11. Wanzel KR, Jamieson CG, Bohnen JM. Complications on a general
surgery service: Incidence and reporting. Can J Surg 2000;43:113-7.
12. Martin RC 2nd, Brennan MF, Jaques DP. Quality of complication
reporting in the surgical literature. Ann Surg 2002;235:803-13.
13. Marang-van de Mheen PJ, van Hanegem N, Kievit J. Effectiveness of
routine reporting to identify minor and serious adverse outcomes in
surgical patients. Qual Saf Health Care 2005;14:378-82.
14. Roukema JA, van der Werken C, Leenen LP. [registration of postoper-
ative complications to improve the results of surgery]. Ned Tijdschr
Geneeskd 1996;140:781-4.
15. Wolterbeek JH, van Leeuwen AA, Breslau PJ. Skin closure after infrain-
guinal bypass surgery: a prospective randomised study. Eur J Vasc
Endovasc Surg 2002;23:321-4.
16. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein
versus polytetrafluoroethylene in above-knee femoropopliteal bypass
grafting: five-year results of a randomized controlled trial. J Vasc Surg
2003;37:149-55.
17. Flu H, Breslau PJ, Krol-van Straaten JM, Hamming JF, Lardenoye JW.
The effect of implementation of an optimized care protocol on the
outcome of arteriovenous hemodialysis access surgery. J Vasc Surg
2008;48:659-68.
18. Flu H, van der Hage JH, Knippenberg B, Merkus JW, Hamming JF,
Lardenoye JW. Treatment for peripheral arterial obstructive disease: An
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 3 Flu et al 627appraisal of the economic outcome of complications. J Vasc Surg
2008;48:368-76.
19. Flu HC, Breslau PJ, Hamming JF, Lardenoye JW. A prospective study
of incidence of saphenous nerve injury after total great saphenous vein
stripping. Dermatol Surg 2008;34:1333-9.
20. Ploeg AJ, Lardenoye JW, Vrancken Peeters MP, Breslau PJ. Contem-
porary series of morbidity and mortality after lower limb amputation.
Eur J Vasc Endovasc Surg 2005;29:633-7.
21. Ploeg AJ, Lange CP, Lardenoye JW, Breslau PJ. The incidence of
unplanned returns to the operating room after peripheral arterial bypass
surgery and its value as indicator of quality of care. Vasc Endovascular
Surg 2008;42:19-24.
22. Ploeg AJ, Lardenoye JW, PeetersMP,Hamming JF, Breslau PJ.Wound
complications at the groin after peripheral arterial surgery sparing the
lymphatic tissue: a double-blind randomized clinical trial. Am J Surg
2009;197:747-51.
23. Ploeg A, Lange C, Lardenoye JW, Breslau P. Nosocomial infections
after peripheral arterial bypass surgery. World J Surg 2007;31:1687-92.
24. Vrancken Peeters MP, Kappetein AP, Lardenoye JH, Breslau PJ. The
value of a mortality-scoring system in the quality control of patients
undergoing abdominal aortic surgery. Eur J Vasc Endovasc Surg 1999;
18:523-6.
25. Marang-van de Mheen PJ, Mertens BJ, van Houwelingen HC, Kievit J.
Surgery groups differed in adverse outcome probabilities and can be
used to adjust hospital comparisons. J Clin Epidemiol 2005;58:56-62.
26. Marang-van de Mheen PJ, Stadlander MC, Kievit J. Adverse outcomes
in surgical patients: Implementation of a nationwide reporting system.
Qual Saf Health Care 2006;15:320-4.
27. Marang-van de Mheen PJ, van Duijn-Bakker N, Kievit J. Adverse
outcomes after discharge: Occurrence, treatment and determinants.
Qual Saf Health Care 2008;17:47-52.
28. Dormandy JA, Rutherford RB. Management of peripheral arterial
disease (PAD). TASC working group. Transatlantic Inter-Society Con-
sensus (TASC). J Vasc Surg 2000;31:S1-296.
29. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin
JL, et al. ACC/AHA guidelines for the management of patients with
peripheral arterial disease (lower extremity, renal, mesenteric, and ab-
dominal aortic): A collaborative report from the American Associations
for Vascular Surgery/Society for Vascular Surgery, Society for Cardio-
vascular Angiography and Interventions, Society for Vascular Medicine
and Biology, Society of Interventional Radiology, and the ACC/AGA
task force on practice guidelines (writing committee to develop guide-
lines for the management of patients with peripheral arterial disease)—
summary of recommendations. J Vasc Interv Radiol 2006;17:1383-97;
quiz 1398.
30. Han KR, Kim HL, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun AS.
Use of American Society of Anesthesiologists physical status classifica-
tion to assess perioperative risk in patients undergoing radical nephrec-tomy for renal cell carcinoma. Urology 2004;63:841-6; discussion
846-7.
31. Marang-van de Mheen PJ, Kievit J. [Automated registration of adverse
events in surgical patients in the Netherlands: the current status]. Ned
Tijdschr Geneeskd 2003;147:1273-7.
32. Lange CP, Ploeg AJ, Lardenoye JW, Breslau PJ. Patient- and procedure-
specific risk factors for postoperative complications in peripheral vascular
surgery. Qual Saf Health Care 2009;18:131-6.
33. Kalra M, Gloviczki P, Bower TC, Panneton JM, Harmsen WS, Jenkins
GD, et al. Limb salvage after successful pedal bypass grafting is associ-
ated with improved long-term survival. J Vasc Surg 2001;33:6-16.
34. Kashyap VS, Ahn SS, Quinones-Baldrich WJ, Choi BU, Dorey F, Reil
TD, et al. Infrapopliteal-lower extremity revascularization with pros-
thetic conduit: a 20-year experience. Vasc Endovascular Surg 2002;36:
255-62.
35. Taylor SM, Kalbaugh CA, Blackhurst DW, Cass AL, Trent EA, Langan
EM 3rd, et al. Determinants of functional outcome after revasculariza-
tion for critical limb ischemia: An analysis of 1000 consecutive vascular
interventions. J Vasc Surg 2006;44:747-55; discussion 755-6.
36. Awad S, Karkos CD, Serrachino-Inglott F, Cooper NJ, Butterfield JS,
Ashleigh R, et al. The impact of diabetes on current revascularisation
practice and clinical outcome in patients with critical lower limb isch-
aemia. Eur J Vasc Endovasc Surg 2006;32:51-9.
37. Abou-Zamzam AM Jr, Gomez NR, Molkara A, Banta JE, Teruya TH,
Killeen JD, et al. A prospective analysis of critical limb ischemia: factors
leading to major primary amputation versus revascularization. Ann Vasc
Surg 2007;21:458-63.
38. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L.
Risk factors, medical therapies and perioperative events in limb salvage
surgery: Observations from the prevent iii multicenter trial. J Vasc Surg
2005;42:456-64; discussion 464-5.
39. Critchley JA, Capewell S. Mortality risk reduction associated with
smoking cessation in patients with coronary heart disease: a systematic
review. JAMA 2003;290:86-97.
40. Hirsch AT, Treat-Jacobson D, Lando HA, Hatsukami DK. The role of
tobacco cessation, antiplatelet and lipid-lowering therapies in the treat-
ment of peripheral arterial disease. Vasc Med 1997;2:243-51.
41. Bannazadeh M, Sarac TP, Bena J, Srivastava S, Ouriel K, Clair D.
Reoperative lower extremity revascularization with cadaver vein for
limb salvage. Ann Vasc Surg 2009;23:24-31.
42. Bhatti AF, Leon LR Jr, Labropoulos N, Rubinas TL, Rodriguez H,
Kalman PG, et al. Free-floating thrombus of the carotid artery: Litera-
ture review and case reports. J Vasc Surg 2007;45:199-205.
43. Goodney PP, Likosky DS, Cronenwett JL. Factors associated with
stroke or death after carotid endarterectomy in northern new england.
J Vasc Surg 2008;48:1139-45.Submitted Apr 17, 2009; accepted Sep 30, 2009.
